The Role of Anticoagulant and Thrombolysis in The Management of Deep Vein Thrombosis

Anggia Endah Satuti(1*), Hariadi Hariawan(2), Hasanah Mumpuni(3)

(*) Corresponding Author


Deep vein thrombosis (DVT) is a clinical challenge encountered by clinicians of all specialties. The major complication to date is thrombus embolization into the lung which can be fatal. The mainstay of DVT therapy is an anticoagulant to prevent the thrombus development and recurrence. However, anticoagulant has no direct thrombolysis effect and recanalization of DVT largely depends on the effectiveness of the endogenous fi brinolytic system. Many agents are developed to improve the outcome and prevent a post thrombotic syndrome (PTS). The aim of this review is to give explanation on the use of anticoagulant, especially vitamin K antagonist, warfarin and thrombolytic therapy in DVT.

Full Text:



Article Metrics

Abstract views : 686 | views : 1292


  • There are currently no refbacks.

Copyright (c) 2017 Acta Cardiologia Indonesiana

ACI (Acta Cardiologia Indonesiana) is indexed by: 



ACI (Acta Cardiologia Indonesiana) is published by:

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Address: Radiopoetro Building 2nd Floor, West Wing, Farmako Street, Sekip, Yogyakarta, Indonesia 55281

ACI (Acta Cardiologia Indonesiana) is endorsed by: